M Doder

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. ncbi Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study
    M Doder
    Division of Neuroscience and MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, London, UK
    Neurology 60:601-5. 2003
  2. ncbi Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain
    D J Brooks
    MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, London, United Kingdom
    Synapse 62:671-81. 2008
  3. ncbi Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations
    W Koller
    University of Miami, Miami, Florida, USA
    Mov Disord 16:858-66. 2001

Detail Information

Publications3

  1. ncbi Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study
    M Doder
    Division of Neuroscience and MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, London, UK
    Neurology 60:601-5. 2003
    ..With PET, the aim of this study was to examine regional cerebral (11)C-WAY 100635 binding to 5-HT(1A) receptors in patients with PD and to correlate it with severity of tremor...
  2. ncbi Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain
    D J Brooks
    MRC Clinical Sciences Centre and Division of Neuroscience, Faculty of Medicine, Imperial College, London, United Kingdom
    Synapse 62:671-81. 2008
    ..MRS 1745, an A(2B) receptor selective antagonist, had no effect on the cerebellar binding of [(11)C]KW-6002 in rats, suggesting that this blockable signal is unlikely to result from an affinity for adenosine A(2B) receptors...
  3. ncbi Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations
    W Koller
    University of Miami, Miami, Florida, USA
    Mov Disord 16:858-66. 2001
    ..Tolcapone provided greater improvements in quality of fife, was better tolerated, and had a more favorable adverse-event profile than pergolide...